{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:19:15Z","timestamp":1790543955276,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/bmt.2014.69","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T09:41:57Z","timestamp":1398678117000},"page":"966-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation"],"prefix":"10.1038","volume":"49","author":[{"given":"C","family":"Castilla-Llorente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G B","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B E","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F R","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,28]]},"reference":[{"key":"BFbmt201469_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2006-01-0254","volume":"108","author":"WM Leisenring","year":"2006","unstructured":"Leisenring WM, Martin PJ, Petersdorf EW, Regan AE, Aboulhosn N, Stern JM et al. An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 2006; 108: 749\u2013755.","journal-title":"Blood"},{"key":"BFbmt201469_CR2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091\u20132101.","journal-title":"N Engl J Med"},{"key":"BFbmt201469_CR3","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1182\/blood-2006-05-021139","volume":"109","author":"DM Hockenbery","year":"2007","unstructured":"Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood 2007; 109: 4557\u20134563.","journal-title":"Blood"},{"key":"BFbmt201469_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/00007890-199512000-00010","volume":"60","author":"PH Baehr","year":"1995","unstructured":"Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 1995; 60: 1231\u20131238.","journal-title":"Transplantation"},{"key":"BFbmt201469_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/sj.bmt.1701613","volume":"23","author":"M Wakui","year":"1999","unstructured":"Wakui M, Okamoto S, Ishida A, Kobayashi H, Watanabe R, Yajima T et al. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 23: 573\u2013578.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/00007890-199811270-00010","volume":"66","author":"D Wu","year":"1998","unstructured":"Wu D, Hockenbery DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 1998; 66: 1319\u20131324.","journal-title":"Transplantation"},{"key":"BFbmt201469_CR7","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1182\/blood-2008-07-168401","volume":"113","author":"M Mielcarek","year":"2009","unstructured":"Mielcarek M, Storer BE, Boeckh M, Carpenter PA, McDonald GB, Deeg HJ et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 2009; 113: 2888\u20132894.","journal-title":"Blood"},{"key":"BFbmt201469_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbmt.2006.05.010","volume":"12","author":"C Castilla","year":"2006","unstructured":"Castilla C, Perez-Simon JA, Sanchez-Guijo FM, Diez-Campelo M, Ocio E, Perez-Persona E et al. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant 2006; 12: 936\u2013941.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1572-0241.2001.03549.x","volume":"96","author":"JM Schwartz","year":"2001","unstructured":"Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F et al. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome. Am J Gastroenterol 2001; 96: 385\u2013393.","journal-title":"Am J Gastroenterol"},{"key":"BFbmt201469_CR10","first-page":"64","volume":"21","author":"WA Ross","year":"2005","unstructured":"Ross WA, Couriel D . Colonic graft-versus-host disease. Curr Opin Gastroenterol 2005; 21: 64\u201369.","journal-title":"Curr Opin Gastroenterol"},{"key":"BFbmt201469_CR11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","volume":"76","author":"PJ Martin","year":"1990","unstructured":"Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR et al. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 1990; 76: 1464\u20131472.","journal-title":"Blood"},{"key":"BFbmt201469_CR12","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062\u20132068.","journal-title":"Blood"},{"key":"BFbmt201469_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbmt.2005.03.006","volume":"11","author":"RA Nash","year":"2005","unstructured":"Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT et al. A phase I\/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 495\u2013505.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR14","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BFbmt201469_CR15","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","volume":"102","author":"MB Maris","year":"2003","unstructured":"Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021\u20132030.","journal-title":"Blood"},{"key":"BFbmt201469_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0016-5107(99)70390-1","volume":"49","author":"RJ Ponec","year":"1999","unstructured":"Ponec RJ, Hackman RC, McDonald GB . Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc 1999; 49: 612\u2013621.","journal-title":"Gastrointest Endosc"},{"key":"BFbmt201469_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt201469_CR18","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BFbmt201469_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2012.09114.x","volume":"157","author":"ML MacMillan","year":"2012","unstructured":"MacMillan ML, Defor TE, Weisdorf DJ . What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score. Br J Haematol 2012; 157: 732\u2013741.","journal-title":"Br J Haematol"},{"key":"BFbmt201469_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/TP.0b013e3181bc2583","volume":"88","author":"M Robin","year":"2009","unstructured":"Robin M, Porcher R, de Castro R, Fisher G, de Latour RP, Ribaud P et al. Initial liver involvement in acute GVHD is predictive for nonrelapse mortality. Transplantation 2009; 88: 1131\u20131136.","journal-title":"Transplantation"},{"key":"BFbmt201469_CR22","first-page":"77","volume-title":"The Pathology of Bone Marrow Transplantation","author":"GB McDonald","year":"1984","unstructured":"McDonald GB Sale GE . The human gastrointestinal tract after allogeneic marrow transplantation in humans. In: Sale GE Shulman HM (eds) The Pathology of Bone Marrow Transplantation. Masson, Inc.: New York, 1984, 77\u2013103."},{"key":"BFbmt201469_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/bmt.2011.137","volume":"47","author":"W Kreisel","year":"2012","unstructured":"Kreisel W, Dahlberg M, Bertz H, Harder J, Potthof K, Deibert P et al. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant 2012; 47: 430\u2013438.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR24","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","volume":"118","author":"JL Ferrara","year":"2011","unstructured":"Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T et al. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 2011; 118: 6702\u20136708.","journal-title":"Blood"},{"key":"BFbmt201469_CR25","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","volume":"119","author":"AC Harris","year":"2012","unstructured":"Harris AC, Ferrara JL, Braun TM, Holler E, Teshima T, Levine JE et al. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood 2012; 119: 2960\u20132963.","journal-title":"Blood"},{"key":"BFbmt201469_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ajh.20976","volume":"82","author":"J Melson","year":"2007","unstructured":"Melson J, Jakate S, Fung H, Arai S, Keshavarzian A . Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol 2007; 82: 881\u2013886.","journal-title":"Am J Hematol"},{"key":"BFbmt201469_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","volume":"8","author":"ML MacMillan","year":"2002","unstructured":"MacMillan ML, Weisdorf DJ, Wagner JE, Defor TE, Burns LJ, Ramsay NK et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002; 8: 387\u2013394.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.bbmt.2010.01.007","volume":"16","author":"J Pidala","year":"2010","unstructured":"Pidala J, Anasetti C . Glucocorticoid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 1504\u20131518.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/bmt.2013.59","volume":"48","author":"K Jamani","year":"2013","unstructured":"Jamani K, Russell JA, Daly A, Stewart D, Savoie L, Duggan P et al. Prognosis of grade 3-4 acute GVHD continues to be dismal. Bone Marrow Transplant 2013; 48: 1359\u20131361.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbmt.2011.06.012","volume":"18","author":"A Xhaard","year":"2012","unstructured":"Xhaard A, Rocha V, Bueno B, de Latour RP, Lenglet J, Petropoulou A et al. Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant 2012; 18: 406\u2013413.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/bbmt.2002.v8.pm11939605","volume":"8","author":"S Arai","year":"2002","unstructured":"Arai S, Margolis J, Zahurak M, Anders V, Vogelsang GB . Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 2002; 8: 155\u2013160.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/01.TP.0000173995.18826.DE","volume":"80","author":"JO Bay","year":"2005","unstructured":"Bay JO, Dhedin N, Goerner M, Vannier JP, Marie-Cardine A, Stamatoullas A et al. Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies. Transplantation 2005; 80: 782\u2013788.","journal-title":"Transplantation"},{"key":"BFbmt201469_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbmt.2005.03.002","volume":"11","author":"PA Carpenter","year":"2005","unstructured":"Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P et al. A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 465\u2013471.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201469_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.bmt.1705762","volume":"40","author":"MA Perales","year":"2007","unstructured":"Perales MA, Ishill N, Lomazow WA, Weinstock DM, Papadopoulos EB, Dastigir H et al. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplant 2007; 40: 481\u2013486.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1365-2141.2006.06321.x","volume":"135","author":"P Bordigoni","year":"2006","unstructured":"Bordigoni P, Dimicoli S, Clement L, Baumann C, Salmon A, Witz F et al. Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease. Br J Haematol 2006; 135: 382\u2013385.","journal-title":"Br J Haematol"},{"key":"BFbmt201469_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.bmt.1704658","volume":"34","author":"JR Passweg","year":"2004","unstructured":"Passweg JR, Orchard K, Buergi A, Gratwohl A, Powles R, Goldman J et al. Autologous\/syngeneic stem cell transplantation to treat refractory GvHD. Bone Marrow Transplant 2004; 34: 995\u2013998.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR37","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.exphem.2008.03.018","volume":"36","author":"Y Taniguchi","year":"2008","unstructured":"Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K et al. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Exp Hematol 2008; 36: 1216\u20131225.","journal-title":"Exp Hematol"},{"key":"BFbmt201469_CR38","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/bmt.2010.17","volume":"45","author":"C Ustun","year":"2010","unstructured":"Ustun C, JillelLa A, Shah R, Sterling K, Deremer D, Savage N et al. Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD (Letter to the Editor). Bone Marrow Transplant 2010; 45: 1658\u20131660.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201469_CR39","first-page":"ELT06","volume":"88","author":"Y Taniguchi","year":"2003","unstructured":"Taniguchi Y, Ikegame K, Yoshihara S, Sugiyama H, Kawase I, Ogawa H . Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen. Haematologica 2003; 88: ELT06.","journal-title":"Haematologica"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201469","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:29:54Z","timestamp":1648045794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,28]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFbmt201469"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.69","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,28]]},"assertion":[{"value":"28 April 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}